BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Christopher Raymond does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ALXOAlx Oncology Holdings | Buy | $9.00 | Mar 2025 | +104.4% | Miss |
 RAREUltragenyx | Buy | $140.00 | Jan 2025 | −53.7% | Miss |
 QTTBQ32 Bio Inc | Buy | $20.00 | Dec 2024 | −36.0% | Miss |
 ACRSAclaris Therapeutics Inc | Buy | $13.00 | Nov 2024 | −55.7% | Miss |
 KPTIKaryopharm Therapeutics Inc | Buy | $5.00 | Nov 2024 | −60.2% | Miss |
 BHVNBiohaven Ltd. | Buy | $76.00 | Sep 2024 | −59.0% | Miss |
 TYRATyra Biosciences Inc | Buy | $33.00 | Aug 2024 | −41.3% | Miss |
 ABVXAbivax SA American Depositary Shares | Buy | $42.00 | Apr 2024 | −53.4% | Miss |
| QTTBQ32 Bio Inc | Buy | $45.00 | Apr 2024 | −94.8% | Hit |
| ALXOAlx Oncology Holdings | Buy | $21.00 | Mar 2024 | −95.9% | Miss |
 MGTXMeiraGTx Holdings PLC | Buy | $25.00 | May 2023 | −26.9% | Miss |
 VRTXVertex Pharmaceuticals Inc | Buy | $385.00 | May 2023 | +8.1% | Hit |
 INOInovio Pharmaceuticals Inc | Buy | $8.00 | Jan 2020 | +197.1% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.